NEW YORK (GenomeWeb News) — A new company founded yesterday in London intends to “facilitate partnerships” between industry and academic genetic and genomic centers of excellence across the city.
The firm, London Genetics, said its main asset is its “ability to commission multi-center studies” and operate as a corporate gateway for “companies seeking to carry out genetics and genomics-based studies in London.
Funded by the London Development Agency, the company said its services would include offering access to “clinical cohorts, translational research, pharmacogenetics, DNA diagnostics and high-throughput genomics.” The company also would have access to bioinformatics and data-handling services.
London Genetics said it has partnerships already in place with a number of institutions, including King’s College; the London School of Tropical Medicine and Hygiene; St. George’s; the University of London; Imperial College; Queen Mary College; and the Institute of Cancer Research.